We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Acadia Healthcare to Serve FBINAA as Treatment Provider
Read MoreHide Full Article
Acadia Healthcare Company Inc. (ACHC - Free Report) recently announced that it has become the select provider of behavioral health and addiction treatment services to the FBI National Academy Associates or FBINAA. Notably, the FBINAA is the second largest association in law enforcement with 44 chapters internationally. Acadia Healthcare is setting up a dedicated 24/7 hotline into which FBINAA members and affiliates can engage in confidential assessment of their needs, and placement into the right program or facility.
Acadia Healthcare is a provider of inpatient behavioral healthcare services. The company operates a network of 591 behavioral healthcare facilities with approximately 17,800 beds in 39 states, the United Kingdom and Puerto Rico. Acadia provides behavioral health and addiction services to its patients in various settings. This includes inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.
Looking ahead, Acadia Healthcare is well positioned to gain from the growing market for behavioral services as awareness on mental health & substance abuse conditions and treatment options is spreading. Apart from the U.S., Acadia Healthcare has significant growth opportunities in the U.K., where the independent mental health hospitals market is growing at a rapid pace. This is primarily due to a large addressable market in the U.K., with approximately 8.7 million people suffering from mental disorders.
However, the company’s high debt level is a concern. We apprehend Acadia Healthcare’s debts to hurt its financial position over the long haul.
Zacks Rank & Key Picks
Currently, Acadia Healthcare carries a Zacks Rank #4 (Sell). Better-ranked stocks in the medical sector include GW Pharmaceuticals plc , NuVasive, Inc. and Baxter International Inc. (BAX - Free Report) . Each of these stocks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Acadia Healthcare to Serve FBINAA as Treatment Provider
Acadia Healthcare Company Inc. (ACHC - Free Report) recently announced that it has become the select provider of behavioral health and addiction treatment services to the FBI National Academy Associates or FBINAA. Notably, the FBINAA is the second largest association in law enforcement with 44 chapters internationally. Acadia Healthcare is setting up a dedicated 24/7 hotline into which FBINAA members and affiliates can engage in confidential assessment of their needs, and placement into the right program or facility.
Acadia Healthcare is a provider of inpatient behavioral healthcare services. The company operates a network of 591 behavioral healthcare facilities with approximately 17,800 beds in 39 states, the United Kingdom and Puerto Rico. Acadia provides behavioral health and addiction services to its patients in various settings. This includes inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.
Looking ahead, Acadia Healthcare is well positioned to gain from the growing market for behavioral services as awareness on mental health & substance abuse conditions and treatment options is spreading. Apart from the U.S., Acadia Healthcare has significant growth opportunities in the U.K., where the independent mental health hospitals market is growing at a rapid pace. This is primarily due to a large addressable market in the U.K., with approximately 8.7 million people suffering from mental disorders.
Price
Price | Quote
However, the company’s high debt level is a concern. We apprehend Acadia Healthcare’s debts to hurt its financial position over the long haul.
Zacks Rank & Key Picks
Currently, Acadia Healthcare carries a Zacks Rank #4 (Sell). Better-ranked stocks in the medical sector include GW Pharmaceuticals plc , NuVasive, Inc. and Baxter International Inc. (BAX - Free Report) . Each of these stocks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>